Bill Status of HB2631  103rd General Assembly

---

Short Description:  MEDICAID-HEPATITIS C-TREATMENT

House Sponsors
Rep. Marcus C. Evans, Jr.

Last Action

Date	Chamber	Action
5/19/2023	House	Rule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance

305 ILCS 5/5-5.12f new

Synopsis As Introduced
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.

Actions 

Date	Chamber	Action
2/15/2023	House	Filed with the Clerk by Rep. Marcus C. Evans, Jr.
2/15/2023	House	First Reading
2/15/2023	House	Referred to Rules Committee
2/28/2023	House	Assigned to Appropriations-Health & Human Services Committee
3/9/2023	House	To Medicaid & Managed Care Subcommittee
3/10/2023	House	Committee/3rd Reading Deadline Extended-Rule May 19, 2023
5/19/2023	House	Rule 19(a) / Re-referred to Rules Committee